A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

Henry L. Gómez, Silvia Neciosup, Célia Tosello, Max Mano, José Bines, Gustavo Ismael, Patrícia X. Santi, Hélio Pinczowski, Yeni Nerón, Marcello Fanelli, Luis Fein, Carlos Sampaio, Guillermo Lerzo, Adolfo Capó, Juan J. Zarba, César Blajman, Mirta S. Varela, Jeovany Martínez-Mesa, Gustavo Werutsky, Carlos H. Barrios
Clinical Breast Cancer , Volume 16 , Issue 1 , 38 – 44  

 

Full link: http://www.clinical-breast-cancer.com/article/S1526-8209(15)00243-8/abstract